Related Experiment Video
Updated: Jul 30, 2026

Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
Published on: March 25, 2015
A multi-domain protein for beta1 integrin-targeted DNA delivery
E Fortunati1, E Ehlert, N D van Loo
1Department of Cell Biology, Erasmus University, Rotterdam, The Netherlands.
Researchers developed a novel protein, (SPKR)4inv, to target plasmid DNA to beta1 integrins. This protein enhances gene delivery efficiency by specifically binding to target cells, overcoming previous conjugation challenges for nonviral vectors.
Area of Science:
- Biotechnology
- Molecular Biology
- Biochemistry
Background:
- Developing effective receptor-targeted nonviral vectors for in vivo gene delivery faces challenges, particularly low efficiency in conjugating protein ligands to DNA carriers.
- Current methods often involve complex and inefficient chemical coupling procedures.
Purpose of the Study:
- To create and characterize a multi-domain protein, (SPKR)4inv, designed for specific targeting of plasmid DNA to beta1 integrins in remodeling tissues.
- To assess the protein's binding affinity, specificity, and its impact on gene transfection efficiency.
Main Methods:
- A multi-domain protein, (SPKR)4inv, was engineered, incorporating a DNA-binding domain, an alpha-helical linker, and a beta1 integrin-binding domain from Yersinia pseudotuberculosis invasin.
- The protein was purified using a bacterial expression system and characterized for its binding to plasmid DNA and beta1 integrins.
- Cell attachment assays and in vitro transfection assays were performed, with and without soluble beta1 integrin for inhibition studies.
Main Results:
- High yields of purified (SPKR)4inv were obtained.
- (SPKR)4inv demonstrated high-affinity binding to both plasmid DNA and beta1 integrins, with significantly higher apparent affinity for beta1 integrins compared to RGDS peptide.
- While (SPKR)4inv-plasmid complexes alone were inactive in transfection, they significantly enhanced transfection efficiencies when combined with cationic lipids (DOTAP/Tween-20) or polymers (polyethylenimine).
- Transfection mediated by (SPKR)4inv was inhibited by soluble beta1 integrin, confirming receptor specificity.
Conclusions:
- The engineered protein (SPKR)4inv facilitates beta1 integrin-specific targeting of plasmid-carrier complexes, circumventing inefficient conjugation chemistry.
- Its modular design allows for the production of similar proteins with varied affinities.
- This approach offers a promising strategy for developing improved nonviral vectors for in vivo gene delivery.
More Related Videos
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Cytoskeletal Linker Proteins - Plakins
Single-Strand DNA Binding Proteins
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Site-Targeted Drug Delivery Systems: Polymeric Carriers